title: The somatostatin analog angiopeptin does not reduce chronic hypoxic pulmonary hypertension in rats.
abstract: Angiopeptin is an analog of somatostatin-14, which has been found to inhibit cellular proliferation in several models of systemic vascular injury. As proliferation plays a major role in pulmonary hypertension, we examined the hypothesis that angiopeptin would inhibit the development of chronic hypoxic pulmonary hypertension in the rat. Angiopeptin was infused intravenously (90-100 microg/kg/day) by minipumps in 10 rats during a 3-week exposure to hypobaric hypoxia and in six normoxic rats. Normal saline was infused in six hypoxic control rats and in seven normoxic control rats. Angiopeptin produced no significant difference in mean pulmonary arterial pressure and resistance, right ventricular weight, or medial thickness of small pulmonary vessels. Vasoconstrictor responses of isolated lungs to acute hypoxia were not affected by angiopeptin. We conclude that angiopeptin, at the high intravenous dose used, does not significantly reduce the development of chronic hypoxic pulmonary hypertension in rats.
authors.affiliation: VA Medical Center and University of Minnesota, Minneapolis 55417, USA.
authors.forename: E J
authors.initials: EJ
authors.lastname: Sidney
authors.forename: V
authors.initials: V
authors.lastname: Hampl
authors.forename: D P
authors.initials: DP
authors.lastname: Nelson
authors.forename: S L
authors.initials: SL
authors.lastname: Archer
authors.forename: M L
authors.initials: ML
authors.lastname: Foegh
authors.forename: S S
authors.initials: SS
authors.lastname: Cathapermal
authors.forename: E K
authors.initials: EK
authors.lastname: Weir
mesh_terms: D000818:Animals; D002317:Cardiovascular Agents / Q000494:pharmacology*; D002908:Chronic Disease / Q000188:drug therapy; D006352:Heart Ventricles / Q000187:drug effects / Q000473:pathology; D006403:Hematologic Tests; D006439:Hemodynamics / Q000187:drug effects; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D000860:Hypoxia / Q000188:drug therapy*; D008168:Lung / Q000098:blood supply / Q000187:drug effects; D008297:Male; D009842:Oligopeptides / Q000097:blood / Q000494:pharmacology*; D009929:Organ Size / Q000187:drug effects; D010456:Peptides, Cyclic; D010477:Perfusion; D011652:Pulmonary Circulation / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000097:blood / Q000494:pharmacology
chemical_list: D002317:Cardiovascular Agents; D009842:Oligopeptides; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin